Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Simulations Plus
NasdaqGS:SLP Community
Create a narrative
Simulations Plus
Undervalued
Overvalued
Simulations Plus
WA
Analyst Price Target
Consensus Narrative from 5 Analysts
Expansion Of Modeling And Simulation Capabilities Will Drive Client Engagement In 2025
Key Takeaways Strong client interest and engagement for fiscal year 2025 could lead to expanded capabilities and significant revenue growth. Integration and cross-selling from recent acquisitions expected to enhance revenue and EBITDA margins, particularly in clinical operations and medical affairs.
View narrative
US$49.40
FV
27.0% undervalued
intrinsic discount
17.29%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
14 days ago
author updated this narrative
Your Valuation for
SLP
Simulations Plus
Your Fair Value
US$
Current Price
US$36.05
25.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
145m
2015
2018
2021
2024
2025
2027
2030
Revenue US$145.2m
Earnings US$16.0m
Advanced
Set as Fair Value